Semax vs Dihexa

Side-by-side comparison of Semax, Dihexa — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Semax Semax (Heptapeptide ACTH Analogue) Cognitive Dihexa Dihexa (PNB-0408) Cognitive
Basics
Molecular type ACTH-Derived NeuropeptideHGF/MET Potentiator
Amino acids 7—
Molecular weight 813.9 Da413.5 Da
Half-life ~minutes (nasal); longer CNS retentionLong-acting (days)
Route(s) Intranasal, SubcutaneousOral, Transdermal, Subcutaneous (research)
Mechanism & Research
Primary mechanism Semax's primary mechanism involves upregulation of brain-derived neurotrophic factor (BDNF) — a neurotrophin critical for neuronal survival, synaptic plasticity, and neurogenesis. In animal models, Semax increases BDNF m… Dihexa binds to and potentiates the HGF/MET signalling axis. HGF-MET signalling drives synaptogenesis — the formation of new neural connections. By dramatically amplifying this pathway, Dihexa promotes dendritic spine de…
Research status Research Compound Research Compound
Evidence summary Semax has been investigated in Russian clinical research since the 1980s. It has been approved in Russia as a drug for stroke, TBI, and cognitive decline. Western research interest has grown, but large RCTs meeting curre… Dihexa research is primarily from Washington State University's McCoy group. Dramatic findings in animal models have generated interest, but human clinical trials are not yet published. Anecdotal reports from users are b…
Protocol & Dosing
Typical dose 200–600 mcg/day (intranasal)10–15 mg/day (oral or transdermal)
Frequency 1–2x dailyDaily or 5 days on / 2 days off
Duration 2–4 weeks cycles4–8 weeks
Timing Morning (or morning + midday); avoid evening to prevent sleep disruptionMorning
Safety
Common side effects
  • Nasal irritation
  • Mild stimulation/anxiety (dose-dependent)
  • Headache (initial)
  • Temporary appetite change
  • Overstimulation (anxiety, irritability at high doses)
  • Headache
  • Insomnia if taken late in day
Contraindications
  • Active psychiatric conditions (bipolar, schizophrenia)
  • Epilepsy/seizure disorders
  • Pregnancy
  • Active cancer (HGF/MET is a tumour growth pathway — significant theoretical concern)
  • Personal/family history of certain cancers (MET-driven tumours)
  • Pregnancy
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Selank, Dihexa, P21 Semax, Selank, P21
Full profile Read full Semax profile → Read full Dihexa profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.